BioPharma Dive 2025年11月24日 FDA probes effects of Takeda rare disease drug after patient death #FDA probes #Takeda rare
Endpoints News 2025年11月21日 AstraZeneca to onshore rare disease portfolio as part of its $50B pledge to the US #announced Friday #billion pledge
Illumina 2025年5月29日 Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis - Illumina #unveils PromoterAI #Illumina unveils